Doxepin Mega Study
Contents
Doxepin
Doxepin

Related

A
Count
A
Treatments
A
Effects
A
User Variables 2
A
Measurements 30

Tags

Doxepin

Treatment Effectiveness

User reported effectiveness ratings Doxepin for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Allergies 0 0 0 0 0 0
Fibromyalgia 0% 20% 13% 60% 7% 15
Vulvodynia 8% 15% 8% 46% 23% 13

Below is the degree of change seen after Doxepin is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Doxepin Info

Property Value
Variable Name Doxepin
Aggregation Method SUM
Analysis Performed At 2020-10-09
Duration of Action 21 days
Filling Value 0
Kurtosis 1.0988095238095
Mean 0.41667 count
Median 0 count
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 22
Number of Measurements 30
Number of Measurements (including those generated by tagged, joined, or child variables) 30
Public true
Onset Delay 30 minutes
Standard Deviation 0.49646638681731
Unit Count
User Variables 2
UPC 035127699356
Variable Category Treatments
Variable ID 93302
Variance 0.24647887323944